CH599249A5 - - Google Patents
Info
- Publication number
- CH599249A5 CH599249A5 CH940376A CH940376A CH599249A5 CH 599249 A5 CH599249 A5 CH 599249A5 CH 940376 A CH940376 A CH 940376A CH 940376 A CH940376 A CH 940376A CH 599249 A5 CH599249 A5 CH 599249A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59896675A | 1975-07-24 | 1975-07-24 | |
| US05/652,000 US4027019A (en) | 1975-07-24 | 1976-01-23 | 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH599249A5 true CH599249A5 (de) | 1978-05-31 |
Family
ID=27083202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH940376A CH599249A5 (de) | 1975-07-24 | 1976-07-22 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4027019A (de) |
| JP (1) | JPS5214760A (de) |
| AT (1) | AT350748B (de) |
| AU (1) | AU501808B2 (de) |
| CA (1) | CA1072948A (de) |
| CH (1) | CH599249A5 (de) |
| DE (2) | DE2633210A1 (de) |
| DK (1) | DK145610C (de) |
| ES (1) | ES450108A1 (de) |
| FI (1) | FI55036C (de) |
| FR (1) | FR2318645A1 (de) |
| GB (1) | GB1557197A (de) |
| IE (1) | IE43581B1 (de) |
| IL (1) | IL50103A (de) |
| MX (1) | MX3417E (de) |
| NL (1) | NL192206C (de) |
| NO (1) | NO143350C (de) |
| NZ (1) | NZ181130A (de) |
| PH (1) | PH12003A (de) |
| PT (1) | PT65402B (de) |
| SE (2) | SE421800B (de) |
| YU (1) | YU39968B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4507290A (en) * | 1981-04-07 | 1985-03-26 | World Health Organization | Esters of 17 α-ethynyl 19-nor-testosterone and 17 α-ethynyl-18-homo-19-nor-testosterone and pharmaceutical compositions containing the same |
| GB8313921D0 (en) * | 1983-05-19 | 1983-06-22 | World Health Org | Contraceptive compositions |
| WO1993013122A1 (de) * | 1991-12-22 | 1993-07-08 | Schering Aktiengesellschaft | 3-methylsulfonylhydrazono- und 3-oxyimino-steroide, ein verfahren zu deren herstellung, diese steroide enthaltende pharmazeutische präparate sowie ihre verwendung zur herstellung von arzneimitteln |
| US6660726B2 (en) | 2000-03-10 | 2003-12-09 | Endeavor Pharmaceuticals | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
| US7459445B2 (en) * | 2000-03-10 | 2008-12-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and topical pharmaceutical formulations of the same |
| US7989436B2 (en) * | 2003-07-23 | 2011-08-02 | Duramed Pharmaceuticals, Inc. | Estrogenic compounds and pharmaceutical formulations comprising the same |
| US6855703B1 (en) | 2000-03-10 | 2005-02-15 | Endeavor Pharmaceuticals | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
| WO2002062391A2 (en) * | 2001-02-02 | 2002-08-15 | Pharmacia Corporation | Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea |
| US6992075B2 (en) * | 2003-04-04 | 2006-01-31 | Barr Laboratories, Inc. | C(14) estrogenic compounds |
| MXPA05010871A (es) * | 2003-04-11 | 2005-11-25 | Barr Lab Inc | Metodos para administrar estrogenos y progestinas. |
| AR039733A1 (es) * | 2003-06-25 | 2005-03-09 | Gador Sa | Proceso para la obtencion de norelgestromin en distintas relaciones de los isomeros e y z |
| HUP0301982A2 (hu) * | 2003-06-30 | 2005-04-28 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás nagy tisztaságú d-(17alfa)-13-etil-17-hidroxi-18,19-dinor-pregn-4-én-20-in-3-on-oxim előállítására |
| HUP0301981A2 (hu) * | 2003-06-30 | 2005-04-28 | Richter Gedeon Vegyészeti Gyár Rt. | Tiszta d-(17alfa)-13-etil-17-hidroxi-18,19-dinor-pregn-4-én-20-in-3-on-3E- és 3Z-oxim izomerek, valamint eljárás az izomer keverékek és a tiszta izomerek előállítására |
| US7816546B2 (en) * | 2003-06-30 | 2010-10-19 | Richter Gedeon Vegyeszeti Gyar Rt. | Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime |
| TW200621796A (en) * | 2004-08-12 | 2006-07-01 | Sicor Inc | Process for the preparation of 3-oximino steroids |
| CA2601773A1 (en) * | 2005-02-03 | 2006-08-10 | Duramed Pharmaceuticals, Inc. | Compositions of unconjugated estrogens and methods for their use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1493161B2 (de) * | 1951-01-28 | 1973-08-30 | 17alpha-aethinyl-18-methyl-19nortestosteronester, verfahren zu ihrer herstellung und diese enthaltendes mittel | |
| US3780073A (en) * | 1966-07-06 | 1973-12-18 | Ortho Pharma Corp | 3-oximes of 19-nortestosterone esters |
| US3532689A (en) * | 1967-04-20 | 1970-10-06 | Ortho Pharma Corp | 3-oxime and 3-oxime esters of 19-nortestosterone |
| NL7306609A (de) * | 1972-05-26 | 1973-11-28 | ||
| US3912768A (en) * | 1972-09-26 | 1975-10-14 | Warner Lambert Co | Norethindrone O-alkyloximes |
-
1976
- 1976-01-23 US US05/652,000 patent/US4027019A/en not_active Expired - Lifetime
- 1976-06-11 NZ NZ181130A patent/NZ181130A/en unknown
- 1976-06-14 PH PH18572A patent/PH12003A/en unknown
- 1976-06-14 FR FR7617973A patent/FR2318645A1/fr active Granted
- 1976-06-15 GB GB24769/76A patent/GB1557197A/en not_active Expired
- 1976-06-28 AU AU15357/76A patent/AU501808B2/en not_active Expired
- 1976-07-06 CA CA256,343A patent/CA1072948A/en not_active Expired
- 1976-07-13 YU YU1733/76A patent/YU39968B/xx unknown
- 1976-07-22 MX MX001792U patent/MX3417E/es unknown
- 1976-07-22 CH CH940376A patent/CH599249A5/xx not_active IP Right Cessation
- 1976-07-22 IL IL50103A patent/IL50103A/xx unknown
- 1976-07-22 JP JP51086661A patent/JPS5214760A/ja active Granted
- 1976-07-23 SE SE7608407A patent/SE421800B/xx not_active IP Right Cessation
- 1976-07-23 DE DE19762633210 patent/DE2633210A1/de active Granted
- 1976-07-23 DE DE2661002A patent/DE2661002C2/de not_active Expired
- 1976-07-23 NL NL7608210A patent/NL192206C/nl not_active IP Right Cessation
- 1976-07-23 PT PT65402A patent/PT65402B/pt unknown
- 1976-07-23 NO NO762583A patent/NO143350C/no unknown
- 1976-07-23 DK DK335876A patent/DK145610C/da not_active IP Right Cessation
- 1976-07-23 IE IE1636/76A patent/IE43581B1/en unknown
- 1976-07-23 ES ES450108A patent/ES450108A1/es not_active Expired
- 1976-07-23 FI FI762116A patent/FI55036C/fi not_active IP Right Cessation
- 1976-07-23 AT AT543976A patent/AT350748B/de not_active IP Right Cessation
-
1979
- 1979-12-14 SE SE7910336A patent/SE445458B/sv not_active IP Right Cessation
Also Published As
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |